IJMS, Free Full-Text

$ 20.00

4.6
(723)
In stock
Description

Over the past 20 years, stem cell therapy has been considered a promising option for treating numerous disorders, in particular, neurodegenerative disorders. Stem cells exert neuroprotective and neurodegenerative benefits through different mechanisms, such as the secretion of neurotrophic factors, cell replacement, the activation of endogenous stem cells, and decreased neuroinflammation. Several sources of stem cells have been proposed for transplantation and the restoration of damaged tissue. Over recent decades, intensive research has focused on gestational stem cells considered a novel resource for cell transplantation therapy. The present review provides an update on the recent preclinical/clinical applications of gestational stem cells for the treatment of protein-misfolding diseases including Alzheimer’s disease (AD), Parkinson’s disease (PD), Huntington’s disease (HD) and amyotrophic lateral sclerosis (ALS). However, further studies should be encouraged to translate this promising therapeutic approach into the clinical setting.

Ijms Free Full Text Disorders Of Sex Developmentnovel Regulators

IJMS, Free Full-Text, spyra two e1

Irwin I. Puc, PhD on LinkedIn: New Paper đź“„ IJMS

IJMS, Free Full-Text, bäumlein 108 led

IJMS, Free Full-Text, bäumlein 108 led

Ijms Free Full Text Functional Characterization Of Gomisin N In

IJMS, Free Full-Text, Wet Strength Tissue Paper

img./DZug0CiiFGMRxICvfmhglTl72eJkfbmt4t8ye

IJMS, Free Full-Text, onoo 2